COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients
Cyclooxygenase (COX)-2 selective inhibitors have been shown to have comparable efficacy to nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Large outcome studies have shown that patients with OA and RA not...
Сохранить в:
| Опубликовано в:: | Arthritis Res Ther |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2002
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC154435/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12716445/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/ar617 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|